SREBF1 and type 2 diabetes mellitus: The current study clearly demonstrates that C. papaya improves glycemic control in liver of HFD–STZ-induced T2DM rats through the regulation of IRS-2, PI3K, SREBP-1c, and GLUT-2 signaling molecules by facilitating glycolysis and inhibiting gluconeogenesis.